Induction of Retinoic Acid Breakdown in Breast Cancer Cells
Author Information
Author(s): MDWG Krekels, A Verhoeven, J van Dun, W Cools, C Van Hove, L Dillen, M-C Coene, W Wouters
Primary Institution: Janssen Research Foundation
Hypothesis
The study investigates how different retinoids induce the oxidative catabolism of all-trans-retinoic acid in MCF-7 breast cancer cells.
Conclusion
The study found that all-trans-retinoic acid catabolism can be significantly induced in MCF-7 cells by various retinoids, with the process being receptor-mediated.
Supporting Evidence
- MCF-7 cells showed low constitutive all-trans-RA catabolism.
- Maximal induction of all-trans-RA catabolism was observed after 16 hours of treatment.
- Induction of all-trans-RA catabolism was inhibited by actinomycin D, indicating a transcriptional regulation.
- Different retinoids induced all-trans-RA catabolism with varying potencies.
Takeaway
This study shows that certain vitamins can help cancer cells break down a specific substance, which might help in treating cancer.
Methodology
MCF-7 cells were treated with various concentrations of retinoids, and the resulting catabolism of all-trans-retinoic acid was measured using a microcolumn assay and HPLC.
Limitations
The exact enzymes involved in retinoic acid catabolism were not identified, and the study was limited to in vitro conditions.
Want to read the original?
Access the complete publication on the publisher's website